Key facts
- It has raised $220K; the latest was Early Stage VC ($170K) in Jan 2026.
- Notable investors include Maine Venture Fund.
- Apriqot has filed 2 Form Ds with the SEC since 2024, most recently Jan 2025 ($80K sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Apriqot
- ·The full record, as it builds
Funding rounds
No funding rounds for Apriqot are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apriqot
Developer of a data analytics platform designed to help organizations understand and improve community health through integrated data. The company offers data analytics tools and services that combine demographic, geographic, and health metrics, enabling public health agencies, health systems, foundations, and community organizations to understand populations accurately and work more efficiently.
- Sector
- Healthcare
- HQ
- Scarborough, ME, United States
- Founded
- 2023
- Employees
- 4
- Website
- apriqot.co/
- Ownership
- Privately Held (backing)
Apriqot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apriqot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apriqot in its N-PORT filings yet. We sweep new filings monthly.